Research

Hormonal

Pharmacological stimulation of GLP-1 receptors significantly reduces plasma glucose and improves glycaemic control in subjects with type 2 diabetes by preserving insulinotropic and glucagonostatic effects.

For individuals with type 2 diabetes, GLP-1 receptor agonists are a highly effective treatment option. They work by mimicking the natural hormone GLP-1 to lower blood sugar levels. This class of medication is a cornerstone of modern diabetes management due to its ability to improve glycaemic control.

GoodSupportsHIGH confidence
pharmacological stimulation of GLP-1 receptors significantly reduces plasma glucose and improves glycaemic control.
Michael A. Nauck et al. · Diabetes Obesity and Metabolism · 2018

Why this rating

Based on a comprehensive review of physiological studies and clinical outcomes.

Source

Incretin hormones: Their role in health and disease

Michael A. Nauck et al. · Diabetes Obesity and Metabolism · 2018

DOI 10.1111/dom.13129

narrative_reviewCited 869×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →